Concepedia

Shinichi Nagase

SN

6

Publications

304

Citations

6

H-Index

2011

Active since

Affiliations

Ono Pharmaceutical (United Kingdom)(Current)

Ono Pharmaceutical (Japan)

University of Sheffield

King's College London

KU Leuven

Shinichi Nagase is an author at Ono Pharmaceutical (United Kingdom) specializing in bone metabolism, medicine, and pharmacotherapy.

Top concepts

Publications per year

2011–2013

6

Publications

6

Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: The OCEAN study

Richard Eastell, Shinichi Nagase, Michiyo Ohyama et al. · Journal of Bone and Mineral Research · 2011 · 126 citations

Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study

Richard Eastell, Shinichi Nagase, Maria Small et al. · Journal of Bone and Mineral Research · 2013 · 75 citations

The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study

Klaus Engelke, Shinichi Nagase, Thomas Fuerst et al. · Journal of Bone and Mineral Research · 2013 · 43 citations · Full text

Pharmacodynamic Effects on Biochemical Markers of Bone Turnover and Pharmacokinetics of the Cathepsin K Inhibitor, ONO‐5334, in an Ascending Multiple‐Dose, Phase 1 Study

Shinichi Nagase, Michiyo Ohyama, Yoshitaka Hashimoto et al. · The Journal of Clinical Pharmacology · 2011 · 27 citations

, , +14

Serum and urine bone resorption markers and pharmacokinetics of the cathepsin K inhibitor ONO‐5334 after ascending single doses in post menopausal women

Shinichi Nagase, Yoshitaka Hashimoto, Maria Small et al. · British Journal of Clinical Pharmacology · 2012 · 18 citations · Full text

Rows per page

1–5 of 6